| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 310.95 mm | 310.95 mm | 310.95 mm | 310.95 mm | 310.95 mm | 310.95 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 21.31 mm | 12.67 mm | 15.49 mm | 11.72 mm |
| Cash used (since last report) | n/a | n/a | 76.75 mm | 45.65 mm | 55.81 mm | 42.22 mm |
| Cash remaining | n/a | n/a | 234.20 mm | 265.30 mm | 255.13 mm | 268.73 mm |
| Runway (months of cash) | n/a | n/a | 11.0 | 20.9 | 16.5 | 22.9 |
| 13F holders | Current |
|---|---|
| Total holders | 166 |
| Opened positions | 37 |
| Closed positions | 18 |
| Increased positions | 60 |
| Reduced positions | 38 |
| 13F shares | Current |
|---|---|
| Total value | 944.24 bn |
| Total shares | 160.98 mm |
| Total puts | 108.70 k |
| Total calls | 148.40 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| Ra Capital Management | 18.20 mm | $149.26 bn |
| GSK GSK | 13.98 mm | $0.00 |
| Maverick Capital | 10.05 mm | $82.39 bn |
| Adage Capital Partners GP, L.L.C. | 9.70 mm | $79.57 bn |
| Adage Capital Management | 9.70 mm | $138.95 mm |
| Shin Nippon Biomedical Laboratories | 9.61 mm | $18.35 mm |
| BlackRock | 7.30 mm | $59.85 bn |
| M28 Capital Management | 6.16 mm | $50.55 bn |
| Driehaus Capital Management | 5.86 mm | $48.04 bn |
| Siren, L.L.C. | 5.72 mm | $46.91 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 25 Nov 24 | Paul Bolno | Ordinary Shares | Sell | Dispose S | No | Yes | 15 | 50,000 | 750.00 k | 217,351 |
| 25 Nov 24 | Paul Bolno | Ordinary Shares | Option exercise | Acquire M | No | Yes | 2.48 | 50,000 | 124.00 k | 267,351 |
| 25 Nov 24 | Paul Bolno | Share Option Ordinary Shares | Option exercise | Dispose M | No | Yes | 2.48 | 50,000 | 124.00 k | 47,778 |
| 15 Nov 24 | Paul Bolno | Ordinary Shares | Sell | Dispose S | No | Yes | 14.32 | 51,234 | 733.67 k | 217,351 |
| 8 Nov 24 | Chris Francis | Ordinary Shares | Sell | Dispose S | No | Yes | 16 | 36,000 | 576.00 k | 0 |
| 8 Nov 24 | Chris Francis | Ordinary Shares | Option exercise | Acquire M | No | Yes | 8.17 | 36,000 | 294.12 k | 36,000 |
| 8 Nov 24 | Chris Francis | Share Option Ordinary Shares | Option exercise | Dispose M | No | No | 8.17 | 36,000 | 294.12 k | 0 |
| 16 Oct 24 | Chris Francis | Ordinary Shares | Sell | Dispose S | No | Yes | 13.5 | 22,500 | 303.75 k | 0 |
| 16 Oct 24 | Chris Francis | Ordinary Shares | Option exercise | Acquire M | No | Yes | 2.83 | 22,500 | 63.68 k | 22,500 |
| 16 Oct 24 | Chris Francis | Ordinary Shares | Sell | Dispose S | No | Yes | 13.75 | 65,625 | 902.34 k | 0 |
